Tharimmune, Inc. (THAR)
NASDAQ: THAR · Real-Time Price · USD
1.680
-0.010 (-0.59%)
At close: Jul 15, 2025, 4:00 PM
1.650
-0.030 (-1.79%)
After-hours: Jul 15, 2025, 4:21 PM EDT
Tharimmune Market Cap
Tharimmune has a market cap or net worth of $6.95 million as of July 15, 2025. Its market cap has increased by 185.20% in one year.
Market Cap
6.95M
Enterprise Value
6.56M
1-Year Change
185.20%
Ranking
Category
Stock Price
$1.68
Market Cap Chart
Since the IPO on January 12, 2022, Tharimmune's market cap has decreased from $41.18M to $6.95M, a decrease of -83.12%. That is a compound annual growth rate of -39.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2025 | 7.12M | 81.33% |
| Dec 31, 2024 | 3.93M | 205.38% |
| Dec 29, 2023 | 1.29M | -71.40% |
| Dec 30, 2022 | 4.49M | -89.09% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.91B |
| Johnson & Johnson | 377.51B |
| AbbVie | 339.94B |
| Novo Nordisk | 305.41B |
| UnitedHealth Group | 275.86B |
| Novartis AG | 236.71B |
| Abbott Laboratories | 229.69B |
| AstraZeneca | 218.74B |